Ginger Johnson, PhD, President, Asset Optimization and Commercialization at Lumanity, formerly Cello Health BioConsulting, featured as a panelist in discussion, “Women in Biotechnology,” moderated by Karen Tkach Tuzman, Senior Editor, BioCentury.
Women in Biotech Progress – Yet Challenges Remain, Update on Female Innovators in Biotech
View
Sep 6, 2021
Related
Healthcare’s Bold New Reality: Key Insights from HLTH 2024
View
Nov 5, 2024
AMCP Nexus 2024 Highlights
View
Nov 1, 2024
Biopharma Dealmaking and Commercialization Readiness
View
Oct 31, 2024
NCPE Annual Symposium 2024: Highlights from Ireland’s HTA Conference
View
Oct 25, 2024
2024 ESMO Congress: Applying a Patient Lens
View
Oct 7, 2024
Learnings from ESMO Congress 2024
View
Oct 2, 2024